课题基金 / 基金详情

pathophysiological significance of insulin-like growth factor binding protein

pathophysiological significance of insulin-like growth factor binding protein
胰岛素样生长因子结合蛋白的病理生理意义
批准号:
03671168
负责人:
TAKANO Kazue
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

TAKANO Kazue的其他基金

相似基金

相关文献

中文摘要
翻译
血清和组织中的胰岛素样生长因子(IGF)与特定的结合蛋白结合。我们用Western配体印迹法研究了不同条件下的血清IGF结合蛋白(igfbp)。IGFBP-3的Western免疫印迹和IGFBP-1的RIA。正常人血清中检测到4种igfbp,分子量分别为41/38、34、30、24KD, Western配体印迹法鉴定为igfbp - 3,2,1,4。生长激素缺乏症患者血清IGFBP-3降低,肢端肥大症患者血清IGFBP-3升高。甲状腺功能减退患者IGFBP-3水平轻度升高,营养不良患者IGFBP-3水平降低,IGFBP-2水平升高。严重肝功能障碍患者所有igfbp均下降。这些数据表明血清IGFBP-3由肝脏产生,并依赖于生长激素和营养状况。在伴有低血糖(NICTH)的非胰岛细胞肿瘤患者中,血清IGFBP-2升高。2例NICTH患者成功切除肿瘤后,IGFBP-2降低,IGFBP-3升高。免疫印迹法检测血清IGFBP-3。正常人血清中IGFBP-3有3个条带,分子量分别为41,38,30kd。这三个IGFBP-3条带在肢端肥大症患者中升高,在生长激素缺乏患者中降低。孕妇血清中显示大量30KD IGFBP-3。在一些NICTH患者中,大部分IGFBP-3为30KD,在成功切除肿瘤后该条带消失。5名正常受试者分别给予0.06mg/kg或0.12mg/kg IGF-I时,RIA测定IGFBP-1在1h升高,5h达到峰值。我们报道了不同条件下的血清IGFBP。这些观察结果有助于研究IGF的生物利用度。
英文摘要
Insulin-like growth factor(IGF)in serum and tissue binds to specific binding proteins. We investigated serum IGF binding proteins(IGFBPs)in various conditions using Western ligand blotting., Western immunoblotting of IGFBP-3 and RIA of IGFBP-1.Serum from normal subjects revealed four IGFBPs with mol wts of 41/38, 34, 30, 24KD identified as IGFBP-3, 2, 1, 4 using Western ligand blotting. Serum IGFBP-3 decreased in the patients with GH deficiency and increased in acromegalic patients. IGFBP-3 sightly increased in patients with hypothyroidism and IGFBP-3 decreased and IGFBP-2 increased in malnutrition. All IGFBPs decreased in patients with severe liver dysfunction. These data show that serum IGFBP-3 was produced from liver and depends on GH and nutritional state. In patients with nonislet cell tumor associated with hypoglycemia(NICTH), serum IGFBP-2 increased. In two patients with NICTH IGFBP-2 decreased and IGFBP-3 increased after successful tumor resection.Serum IGFBP-3 was also studied using Western immunoblotting. Serum from normal subjects revealed three bands of IGFBP-3 with mol wts of 41, 38, 30KD. These three bands of IGFBP-3 increased in acromegalic patients and decreased in patients with GH deficiency. Serum in pregnant wemen shows a large amount of 30KD IGFBP-3. In some patients with NICTH most of all IGFBP-3 was 30KD and this band disappeared after successful tumor resection.When 0.06mg/kg or 0.12mg/kg IGF-I was administered to 5 normal subjects, IGFBP-1, which was measured using RIA, increased at 1h and reached the peak at 5hs.We reported serum IGFBP in various conditions. These observations are useful for studying IGF bioavailability.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Tanaka T.et al.: "Growth hormone secretion and therapeutic effects of human growth hnmone:First Gaparse rsults of kabi Phormacic international growth study/international woperatiae growth study." Acta Paediatr Scand.379. 126-135 (1991)
Tanaka T.et al.:“生长激素分泌和人类生长激素的治疗​​效果:kabi Phormacic 国际生长研究/国际 woperatiae 生长研究的第一个 Gaparse 结果。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hizuka N.et al.: "Modern concepts of insulin-like growth factors" Spencer E.M., 51-55 (1991)
Hizuka N.et al.:“胰岛素样生长因子的现代概念”Spencer E.M.,51-55 (1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takano K. et al.: "Treatment of 46 patients with Turner′s syndrome with recombin ant human growth hormone(YM-17798)for three yeas. -Multi contre study-" A ct a Endocripologica. 126. 296-302 (1992)
Takano K. 等人:“用重组人生长激素 (YM-17798) 治疗 46 名特纳氏综合征患者三年。-多重对照研究-”Act a Endocripologica. 126. 296-302 (1992)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
高野 加寿恵 他: "成人下垂体性小人症における遺伝子組換えヒト型IGFーI(FK780)単回及び連日7日間投与の安定性および血中動態の検討" 薬理と治療. 20. 557-567 (1992)
Kazue Takano 等人:“成人垂体侏儒症中单次和每日 7 天施用重组人 IGF-I (FK780) 的稳定性和血液动力学研究”药理学和治疗 (Pharmacology and Treatment) 20. 557-567 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Study for pathophysiological significance of growth hormone (GH) and insulin-like growth factor in metabolic disorders
    • 批准号:
      17590968
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2005
    • 负责人:
      TAKANO Kazue
    • 依托单位:
    Study for pathophysiological significance of growth hormone in adult men.
    • 批准号:
      14571074
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      2002
    • 负责人:
      TAKANO Kazue
    • 依托单位:
    Study for biological effect of IGF-II and the Pathological significance.
    • 批准号:
      06671059
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1994
    • 负责人:
      TAKANO Kazue
    • 依托单位:
    The study of growth disorder in basic of abnormality of GH secretion
    • 批准号:
      63570548
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1988
    • 负责人:
      TAKANO Kazue
    • 依托单位:
    国内基金
    海外基金
    miR-483-5p上调IGF-II基因表达的调控机制及与肝细胞癌预后关系的研究
    • 批准号:
      81572369
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2015
    • 负责人:
      汤绍辉
    • 依托单位:
    IGF-II mRNA结合蛋白IMP3对人肾细胞癌侵袭、转移的调控机制研究
    • 批准号:
      81001135
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      22.0万元
    • 批准年份:
      2010
    • 负责人:
      贺慧颖
    • 依托单位:
    TCDD致骨骼畸形的IGF-II基因表观变异研究
    • 批准号:
      30500414
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2005
    • 负责人:
      赵玉岩
    • 依托单位:
    用IGF-II P4启动子调控治疗基因在肝癌细胞表达并诱导凋亡